International biopharma specializing in rare diseases and critical care connects R&D, quality, commercial, and data on the ³Ô¹Ï±¬ÁÏ Vault Platform to accelerate innovation<\/i><\/p>\n
PLEASANTON, CA and VIENNA, Austria \u2014 March 10, 2026 \u2014<\/strong> ³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) today announced that AOP Health<\/a>, an international leader in integrated therapies for rare diseases and critical care, is standardizing on applications across the ³Ô¹Ï±¬ÁÏ Vault Platform to drive faster global growth. By connecting clinical research, development, quality, and commercialization on ³Ô¹Ï±¬ÁÏ Development Cloud<\/a>, Quality Cloud<\/a>, Commercial Cloud<\/a>, and Data Cloud<\/a>, AOP Health can streamline operations, eliminate silos, and accelerate delivery of critical medicines to patients.<\/p>\n \u201cAOP Health\u2019s mission is to provide integrated therapy solutions that improve the lives of patients with rare and critical conditions. For almost 30 years, AOP Health has been dedicated to this purpose,\u201d said Bernard Seiser, vice president, Digital, Data, and IT at AOP Health. \u201cBy upgrading our technology foundation and connecting key teams from development to commercial, ³Ô¹Ï±¬ÁÏ Industry Cloud for Life Sciences supports this longstanding work and empowers AOP Health to scale seamlessly and speed time-to-patient.\u201d<\/p>\n AOP Health specializes in integrated therapies for rare diseases and intensive care medicine. With a single technology foundation, AOP Health will enable clinical, regulatory, safety, and quality teams to develop new treatments more efficiently, while strengthening quality, drug safety, and compliance. For commercial and data teams, a common platform will help ensure closer collaboration across sales, marketing, and medical, for seamless customer experiences with greater insight.<\/p>\n \u201cAOP Health\u2019s vision is clear\u2014connected cloud strategy drives efficiency, enables growth, and helps deliver better outcomes for patients,\u201d said Rik van Mol, senior vice president, Development Cloud Strategy, ³Ô¹Ï±¬ÁÏ. \u201cOur collaboration is built on shared values and the goal to transform how AOP serves the rare disease and critical care communities with ³Ô¹Ï±¬ÁÏ Industry Cloud for Life Sciences.\u201d<\/p>\n Additional Information<\/strong> About AOP Health<\/strong> About ³Ô¹Ï±¬ÁÏ Systems<\/strong> ³Ô¹Ï±¬ÁÏ Forward-Looking Statements<\/strong> \nContact:<\/strong><\/p>\n \nJeremy Whittaker
\nConnect with ³Ô¹Ï±¬ÁÏ on LinkedIn: linkedin.com\/company\/veeva-systems<\/a> <\/p>\n
\nAOP Health<\/a> is a global enterprise group with roots in Austria, where the headquarters of AOP Orphan Pharmaceuticals GmbH (\u201cAOP Health\u201d) is located. Since 1996, the AOP Health Group has been dedicated to developing innovative solutions to address unmet medical needs, particularly in the fields of rare diseases and intensive care medicine. The group has established itself internationally as a pioneer in integrated therapy solutions and operates worldwide through subsidiaries, representations, and a strong network of partners. With the claim \u201cNeeds. Science. Trust.\u201d, the AOP Health Group emphasizes its commitment to research and development, as well as the importance of building relationships with physicians and patient advocacy groups to ensure that the needs of these stakeholders are reflected in all aspects of the company\u2019s actions. <\/p>\n
\n³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.<\/p>\n
\nThis release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.<\/p>\n
\n³Ô¹Ï±¬ÁÏ Systems
\njeremy.whittaker@veeva.com<\/a>\n<\/p>\n